DOCSLIB.ORG

ALS-Linked Mutant Superoxide Dismutase 1 (SOD1) Alters Mitochondrial Protein Composition and Decreases Protein Import

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ALS-Linked Mutant Superoxide Dismutase 1 (SOD1) Alters Mitochondrial Protein Composition and Decreases Protein Import ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import Quan Lia,1, Christine Vande Veldeb,c,1, Adrian Israelsonb, Jing Xied, Aaron O. Baileye, Meng-Qui Donge, Seung-Joo Chuna, Tamal Royb, Leah Winera, John R. Yatese, Roderick A. Capaldid, Don W. Clevelandb,2, and Timothy M. Millera,b,2 aDepartment of Neurology, Hope Center for Neurological Disorders, The Washington University School of Medicine, St. Louis, MO 63110; bLudwig Institute and Departments of Cellular and Molecular Medicine and Neuroscience, University of California at San Diego, La Jolla, CA 92093-0670; cDepartment of Medicine, Centre Hospitalier de l’Université de Montréal Research Center, Université de Montréal, Montreal, QC, Canada H2L 4M1; eDepartment of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037; and dMitoSciences, Eugene, OR 97403 Contributed by Don W. Cleveland, October 18, 2010 (sent for review February 4, 2010) Mutations in superoxide dismutase 1 (SOD1) cause familial ALS. system very little SOD1 is found in or on mitochondria (20, 21), Mutant SOD1 preferentially associates with the cytoplasmic face of but mutant SOD1 has been found associated presymptomatically mitochondria from spinal cords of rats and mice expressing SOD1 with the cytoplasmic face of mitochondria from spinal cord in all mutations. Two-dimensional gels and multidimensional liquid chro- rodent models of SOD1 mutant-mediated disease (20, 21). A matography, in combination with tandem mass spectrometry, criticism that apparent association of dismutase inactive mutants fl revealed 33 proteins that were increased and 21 proteins that with mitochondria might re ect cosedimentation of protein G93A aggregates rather than bona fide mitochondrial association (22) were decreased in SOD1 rat spinal cord mitochondria com- fl pared with SOD1WT spinal cord mitochondria. Analysis of this has been refuted by demonstrating that mutant SOD1 oats with group of proteins revealed a higher-than-expected proportion in- mitochondria rather than sedimenting as much more dense pro- tein-only aggregates would under such conditions (21). Indeed, volved in complex I and protein import pathways. Direct import a portion of misfolded mutant SOD1 directly binds to the cyto- assays revealed a 30% decrease in protein import only in spinal plasmic facing surface of the major voltage-dependent anion cord mitochondria, despite an increase in the mitochondrial import G93A channel (VDAC1), a general diffusion pore for anions and cati- components TOM20, TOM22, and TOM40. Recombinant SOD1 ons that is located on the outer mitochondrial membrane. Mutant G85R WT ’ or SOD1 , but not SOD1 or a Parkinson s disease-causing, mis- SOD1 binding reduces conductance by purified VDAC1 recon- α E46K > folded -synuclein mutant, decreased protein import by 50% stituted in a lipid bilayer, and spinal cord mitochondria have re- in nontransgenic mitochondria from spinal cord, but not from liver. duced ADP uptake (23). Thus, altered mitochondrial protein content accompanied by selec- Three prior efforts have reported use of proteomic tools to in- tive decreases in protein import into spinal cord mitochondria com- vestigate how mutant SOD1 affects mitochondrial protein com- prises part of the mitochondrial damage arising from mutant SOD1. position within whole-spinal-cord extracts of dismutase-active (24) or dismutase-inactive (25) SOD1 mutant mouse models or, more motor neuron disease | proteomic | neurodegenerative disease | selectively, within mitochondria of a cell line retaining some motor amyotrophic neuron-like properties and expressing one dismutase-active, ALS- linked SOD1 mutant (26). We extended these approaches to de- myotrophic lateral sclerosis (ALS) is an adult-onset neuro- termine whether mutant SOD1 affects protein content of spinal Adegenerative disorder caused by loss of the motor neurons cord mitochondria before disease initiation in rodent models that within the spinal cord and dysfunction of the motor pathways in the develop ALS-like disease. Using a combination of mass spectrom- cortex (1, 2). Most cases of ALS (90%) are sporadic. Of the 10% of etry and 2D gels, we now report 21 proteins to be decreased ap- cases that are inherited, about one-fifth are caused by mutation proximately twofold, with another 33 that are increased by a within the superoxide dismutase 1 (SOD1) gene. Rodents expres- comparable amount or more in mitochondria isolated from spinal cords of mutant SOD1 animals, accompanied by diminished pro- sing mutant SOD1 develop an ALS-like disease (1, 2). A consensus fi has emerged that disease arises from acquisition by the mutant tein import activity. By using puri ed components, inhibition of proteins of one or more toxic properties, rather than from loss of mitochondrial protein import is demonstrated to be a direct result dismutase activity (3, 4). At least eight prominent mutant-derived of mutant but not wild-type SOD1. toxicities have been proposed, including mitochondrial dysfunc- Results tion, excitotoxicity, endoplasmic reticulum stress, toxic extracel- lular SOD1, superoxide production from microglia or astrocytes, Altered Spinal Cord Mitochondrial Protein Content in SOD1 Mutant and disruption of the blood–brain barrier (5). Furthermore, Rats. To identify possible differences in protein composition be- pathogenesis is noncell autonomous with disease progression tween mitochondria isolated from spinal cords of age-matched driven by mutant synthesis in astrocytes (6–8) and microglia (3, 9). SOD1WT and SOD1G93A mutant rats, we used 2D gel electro- Dysfunction of mitochondria can clearly cause specific damage phoresis as well as liquid chromatography followed by tandem to neurons or muscle because deletion/mutation in mitochondrial mass spectrometry [multidimensional protein identification tech- genes causes specific nerve and muscle diseases (10). Accompa- nying mutant SOD1-mediated disease in some mice is evidence for altered mitochondrial calcium-buffering capacity (11) and Author contributions: Q.L., C.V.V., R.A.C., D.W.C., and T.M.M. designed research; Q.L., C.V.V., changes in the activity of complexes of the electron transport chain A.I., J.X., A.O.B., M.-Q.D., S.-J.C., T.R., L.W., and T.M.M. performed research; Q.L., C.V.V., A.I., (12). Deletion of the mitochondrial BCL-2–related proteins BAX J.X., A.O.B., M.-Q.D., S.-J.C., T.R., L.W., J.R.Y., R.A.C., D.W.C., and T.M.M. analyzed data; and and BAK delays disease onset in SOD1G93A mice (13), perhaps Q.L., C.V.V., D.W.C., and T.M.M. wrote the paper. by modulating effects of SOD1 conformational changes to BCL-2 The authors declare no conflict of interest. (14). Apparent damage to mitochondria has been reported in 1Q.L. and C.V.V. contributed equally to this work. autopsy material from ALS patients (15, 16). 2To whom correspondence may be addressed. E-mail: [email protected] or Although SOD1 is a primarily cytosolic enzyme, wild-type [email protected]. SOD1 is also found in the intermembrane space of mitochondria This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. in liver (17) and in yeast (18, 19). However, in the normal nervous 1073/pnas.1014862107/-/DCSupplemental. 21146–21151 | PNAS | December 7, 2010 | vol. 107 | no. 49 www.pnas.org/cgi/doi/10.1073/pnas.1014862107 Downloaded by guest on September 24, 2021 G93A nology (MudPIT)] (27). Initially, a presymptomatic age (11 wk) Decreased Complex I Activity in Mitochondria from SOD1 Rats. was chosen because it was known to correspond to a time of Six (NDUFS1, ND5, NDUFB8, NDUFC2, NDUFA5, NDUFB9) very active denervation of lower motor neurons (28). Although of the 26 down-regulated proteins in mitochondria from mutant a change in staining on 2D gels may reflect altered abundance, spinal cord are components of the 42-subunit complex I, also size, or isoelectric point, the overall patterns of major proteins known as NADH dehydrogenase. Complex I is located on the (visible in Coomassie (Fig. 1) or silver (Fig. S1) staining were inner membrane of mitochondria, catalyzes the shuttling of elec- highly similar. Twelve spots (Fig. 1 B and C compared with Fig. 1 trons from NADH to coenzyme Q, and helps to build the proton E and F and Fig. S1 B and C compared with Fig. S1 E and F) were gradient required for ATP generation. Immunoprecipitation of clearly different between the two samples, with five (spots 1, 6, 7, mitochondrial extracts with a monoclonal antibody raised against 8, and 9) increased in SOD1G93A mitochondria and seven (spots complex I, which had been crosslinked to protein G agarose beads (32), confirmed that at least six complex I polypeptides were 2–5 and 10–12) decreased. Each was excised, digested with tryp- changed in relative abundance: two were increased [(V1, S2) and sin, and identified via tandem mass spectrometry (Table S1). (A10, ND5)] and four were decreased [S1, (A9, D1), S3, and (B10, Three spots contained more than one protein, resulting in a total fi V2; B7, A5, B4, B5, B6, S5, B16, 6, A7)] (some stained bands of 15 proteins identi ed. represent multiple polypeptides) (Fig. 3A). Of those decreased in Using MudPIT mass spectrometry, protein differences were G93A fi SOD1 mitochondria, a polypeptide migrating at 75 kDa (Fig. also identi ed from three independent preparations of mitochon- 3A) most likely represents S1 (also known as NDUFS1) (32–34), dria from 11-wk-old SOD1WT and age-matched presymptomatic G93A which was also seen to be decreased by mass spectrometry (Table SOD1 rat spinal cords, using normalized spectral counts as an 1) and 2D gels (Fig. 3B, arrows). A prominent complex I poly- indication of the relative amount of any given protein (29, 30). peptide migrating at 35 kDa, most likely representing ND5 (32– We identified 299 mitochondrial proteins present in all of the 34), was increased in immunoprecipitates.
Load more

Recommended publications
  • Role of Tomm40'523 – Apoe Haplotypes in Alzheimer's Disease Etiology
    ROLE OF TOMM40’523 – APOE HAPLOTYPES IN ALZHEIMER’S DISEASE ETIOLOGY – FROM CLINICS TO MITOCHONDRIA RÈMY CARDOSO Tese para obtenção do grau de Doutor em EnvelHecimento e Doenças Crónicas Doutoramento em associação entre: Universidade NOVA de Lisboa (Faculdade de Ciências Médicas | NOVA Medical ScHool - FCM|NMS/UNL) Universidade de Coimbra (Faculdade de Medicina - FM/UC) Universidade do MinHo (Escola de Medicina - EMed/UM) Novembro, 2020 ROLE OF TOMM40’523 – APOE HAPLOTYPES IN ALZHEIMER’S DISEASE ETIOLOGY – FROM CLINICS TO MITOCHONDRIA Rèmy Cardoso Professora Doutora Catarina Resende Oliveira, Professora Catedrática Jubilada da FM/UC Professor Doutor Duarte Barral, Professor Associado da FCM|NMS/UNL Tese para obtenção do grau de Doutor em EnvelHecimento e Doenças Crónicas Doutoramento em associação entre: Universidade NOVA de Lisboa (Faculdade de Ciências Médicas | NOVA Medical ScHool - FCM|NMS/UNL) Universidade de Coimbra (Faculdade de Medicina - FM/UC) Universidade do MinHo (Escola de Medicina - EMed/UM) Novembro, 2020 This thesis was conducted at the Center for Neuroscience and Cell Biology (CNC.CIBB) of University of Coimbra and Coimbra University Hospital (CHUC) and was a collaboration of the following laboratories and departments with the supervision of Catarina Resende Oliveira MD, PhD, Full Professor of FM/UC and the co-supervision of Duarte Barral PhD, Associated professor of Nova Medical School, Universidade Nova de Lisboa: • Neurogenetics laboratory (CNC.CIBB) headed by Maria Rosário Almeida PhD • Neurochemistry laboratory (CHUC)
    [Show full text]
  • Mff Regulation of Mitochondrial Cell Death Is a Therapeutic
    Author Manuscript Published OnlineFirst on October 3, 2019; DOI: 10.1158/0008-5472.CAN-19-1982 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Rev. Ms. CAN-19-1982 MFF REGULATION OF MITOCHONDRIAL CELL DEATH IS A THERAPEUTIC TARGET IN CANCER Jae Ho Seo1,2, Young Chan Chae1,2,3*, Andrew V. Kossenkov4, Yu Geon Lee3, Hsin-Yao Tang4, Ekta Agarwal1,2, Dmitry I. Gabrilovich1,2, Lucia R. Languino1,5, David W. Speicher1,4,6, Prashanth K. Shastrula7, Alessandra M. Storaci8,9, Stefano Ferrero8,10, Gabriella Gaudioso8, Manuela Caroli11, Davide Tosi12, Massimo Giroda13, Valentina Vaira8,9, Vito W. Rebecca6, Meenhard Herlyn6, Min Xiao6, Dylan Fingerman6, Alessandra Martorella6, Emmanuel Skordalakes7 and Dario C. Altieri1,2* 1Prostate Cancer Discovery and Development Program 2Immunology, Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, PA 19104 USA 3School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan 44919, Republic of Korea 4Center for Systems and Computational Biology, The Wistar Institute, Philadelphia, PA 19104, USA 5Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107 USA 6Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, PA 19104, USA 7Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA 19104, USA 1 Downloaded from cancerres.aacrjournals.org on September 29, 2021. © 2019 American Association for Cancer Research. Author Manuscript
    [Show full text]
  • Hippocampal Thinning Linked to Longer TOMM40 Poly-T Variant Lengths in the Absence of the APOE &Epsi
    Alzheimer’s & Dementia - (2017) 1-10 Featured Article Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant Alison C. Burggrena,b,c,*, Zanjbeel Mahmoodb, Theresa M. Harrisona,b,d, Prabha Siddarthb,c,e, Karen J. Millerb,c,e, Gary W. Smallb,c,e, David A. Merrillb,c,e, Susan Y. Bookheimera,b,c,f aCenter for Cognitive Neurosciences, University of California, Los Angeles, CA, USA bDepartment of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA cSemel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, CA, USA dInterdepartmental Graduate Program in Neuroscience, University of California, Los Angeles, CA, USA eDivision of Geriatric Psychiatry, Longevity Center, University of California, Los Angeles, CA, USA fDepartment of Psychology, University of California, Los Angeles, CA, USA Abstract Introduction: The translocase of outer mitochondrial membrane 40 (TOMM40), which lies in link- age disequilibrium with apolipoprotein E (APOE), has received attention more recently as a prom- ising gene in Alzheimer’s disease (AD) risk. TOMM40 influences AD pathology through mitochondrial neurotoxicity, and the medial temporal lobe (MTL) is the most likely brain region for identifying early manifestations of AD-related morphology changes. Methods: In this study, we examined the effects of TOMM40 using high-resolution magnetic reso- nance imaging in 65 healthy, older subjects with and without the APOE ε4 AD-risk variant. Results: Examining individual subregions within the MTL, we found a significant relationship be- tween increasing poly-T lengths of the TOMM40 variant and thickness of the entorhinal cortex only in subjects who did not carry the APOE ε4 allele.
    [Show full text]
  • TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer's Disease
    Author's personal copy Transl. Stroke Res. DOI 10.1007/s12975-012-0161-1 ORIGINAL ARTICLE TOMM40 in Cerebral Amyloid Angiopathy Related Intracerebral Hemorrhage: Comparative Genetic Analysis with Alzheimer’s Disease Valerie Valant & Brendan T. Keenan & Christopher D. Anderson & Joshua M. Shulman & William J. Devan & Alison M. Ayres & Kristin Schwab & Joshua N. Goldstein & Anand Viswanathan & Steven M. Greenberg & David A. Bennett & Philip L. De Jager & Jonathan Rosand & Alessandro Biffi & the Alzheimer’s Disease Neuroimaging Initiative (ADNI) Received: 6 February 2012 /Revised: 13 March 2012 /Accepted: 21 March 2012 # Springer Science+Business Media, LLC 2012 Abstract Cerebral amyloid angiopathy (CAA) related in- CAA-related ICH and CAA neuropathology. Using cohorts tracerebral hemorrhage (ICH) is a devastating form of stroke from the Massachusetts General Hospital (MGH) and the with no known therapies. Clinical, neuropathological, and Alzheimer’s Disease Neuroimaging Initiative (ADNI), we genetic studies have suggested both overlap and divergence designed a comparative analysis of high-density SNP geno- between the pathogenesis of CAA and the biologically type data for CAA-related ICH and AD. APOE ε4was related condition of Alzheimer’s disease (AD). Among the associated with CAA-related ICH and AD, while APOE genetic loci associated with AD are APOE and TOMM40, a ε2 was protective in AD but a risk factor for CAA. A total gene in close proximity to APOE. We investigate here of 14 SNPs within TOMM40 were associated with AD (p< whether variants within TOMM40 are associated with 0.05 after multiple testing correction), but not CAA-related Electronic supplementary material The online version of this article (doi:10.1007/s12975-012-0161-1) contains supplementary material, which is available to authorized users.
    [Show full text]
  • Alzheimer's Disease Susceptibility Genes APOE and TOMM40, And
    Neurobiology of Aging 35 (2014) 1513.e25e1513.e33 Contents lists available at ScienceDirect Neurobiology of Aging journal homepage: www.elsevier.com/locate/neuaging Alzheimer’s disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936 Donald M. Lyall a,b,c,d,e, Sarah E. Harris a,d,e, Mark E. Bastin a,b,f, Susana Muñoz Maniega a,b,f, Catherine Murray a,c, Michael W. Lutz g,h, Ann M. Saunders g, Allen D. Roses g,h,i, Maria del C. Valdés Hernández a,b,f, Natalie A. Royle a,b,f, John M. Starr a,j, David. J. Porteous a,d,e, Joanna M. Wardlaw a,b,f, Ian J. Deary a,c,* a Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK b Brain Research Imaging Centre, Division of Neuroimaging Sciences, University of Edinburgh, Edinburgh, UK c Department of Psychology, University of Edinburgh, Edinburgh, UK d Medical Genetics Section, University of Edinburgh Centre for Genomics and Experimental Medicine, Western General Hospital, Edinburgh, UK e MRC Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, UK f Scottish Imaging Network, A Platform for Scientific Excellence (SINAPSE) Collaboration, Department of Neuroimaging Sciences, The University of Edinburgh, Edinburgh, UK g Department of Neurology, Joseph & Kathleen Bryan Alzheimer’s Disease Research Center, Durham, NC, USA h Duke University Medical Center, Durham, NC, USA i Zinfandel Pharmaceuticals, Inc, Durham, NC, USA j Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK article info abstract Article history: Apolipoprotein E (APOE) ε genotype has previously been significantly associated with cognitive, brain Received 12 August 2013 imaging, and Alzheimer’s disease-related phenotypes (e.g., age of onset).
    [Show full text]
  • Multivariate Genome Wide Association and Network Analysis of Subcortical Imaging Phenotypes in Alzheimer's Disease
    Meng et al. BMC Genomics 2020, 21(Suppl 11):896 https://doi.org/10.1186/s12864-020-07282-7 RESEARCH Open Access Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer’s disease Xianglian Meng1, Jin Li2, Qiushi Zhang3, Feng Chen2, Chenyuan Bian2, Xiaohui Yao4, Jingwen Yan5,6, Zhe Xu1, Shannon L. Risacher5, Andrew J. Saykin5, Hong Liang2* , Li Shen4* and for the Alzheimer’s Disease Neuroimaging Initiative From The International Conference on Intelligent Biology and Medicine (ICIBM) 2020 Virtual. 9-10 August 2020 Abstract Background: Genome-wide association studies (GWAS) have identified many individual genes associated with brain imaging quantitative traits (QTs) in Alzheimer’s disease (AD). However single marker level association discovery may not be able to address the underlying biological interactions with disease mechanism. Results: In this paper, we used the MGAS (Multivariate Gene-based Association test by extended Simes procedure) tool to perform multivariate GWAS on eight AD-relevant subcortical imaging measures. We conducted multiple iPINBPA (integrative Protein-Interaction-Network-Based Pathway Analysis) network analyses on MGAS findings using protein-protein interaction (PPI) data, and identified five Consensus Modules (CMs) from the PPI network. Functional annotation and network analysis were performed on the identified CMs. The MGAS yielded significant hits within APOE, TOMM40 and APOC1 genes, which were known AD risk factors, as well as a few new genes such as LAMA1, XYLB, HSD17B7P2, and NPEPL1. The identified five CMs were enriched by biological processes related to disorders such as Alzheimer’s disease, Legionellosis, Pertussis, and Serotonergic synapse. Conclusions: The statistical power of coupling MGAS with iPINBPA was higher than traditional GWAS method, and yielded new findings that were missed by GWAS.
    [Show full text]
  • Genome-Wide Association Meta-Analysis for Early Age-Related
    bioRxiv preprint doi: https://doi.org/10.1101/2019.12.20.883801; this version posted December 20, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Genome-wide association meta-analysis for early age-related 2 macular degeneration highlights novel loci and insights for 3 advanced disease 4 5 Authors 6 Thomas W Winkler1*, Felix Grassmann2,3*, Caroline Brandl1,2,4, Christina Kiel2, Felix Günther1,5, 7 Tobias Strunz2, Lorraine Weidner1, Martina E Zimmermann1, Christina A. Korb6, Alicia 8 Poplawski7, Alexander K Schuster6, Martina Müller-Nurasyid8,9,10, Annette Peters11,12, 9 Franziska G Rauscher13,14, Tobias Elze13,15, Katrin Horn13,14, Markus Scholz13,14, Marisa 10 Cañadas-Garre16, Amy Jayne McKnight16, Nicola Quinn16, Ruth E Hogg16, Helmut Küchenhoff5, 11 Iris M Heid1§, Klaus J Stark1§ and Bernhard HF Weber2§ 12 Affiliations 13 1: Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany; 2: Institute of Human Genetics, 14 University of Regensburg, Regensburg, Germany; 3: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 15 Stockholm, Sweden; 4: Department of Ophthalmology, University Hospital Regensburg, Regensburg, Germany; 5: Statistical 16 Consulting Unit StaBLab, Department of Statistics, Ludwig-Maximilians-Universität Munich, Munich, Germany; 6: Department of 17 Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; 7:
    [Show full text]
  • And Risk for Alzheimer Disease
    ARTICLE OPEN ACCESS Use of local genetic ancestry to assess TOMM40-5239 and risk for Alzheimer disease Parker L. Bussies, BS, Farid Rajabli, PhD, Anthony Griswold, PhD, Daniel A. Dorfsman, BA, Correspondence Patrice Whitehead, BS, Larry D. Adams, BA, Pedro R. Mena, MD, Michael Cuccaro, PhD, Dr. Vance [email protected] Jonathan L. Haines, PhD, Goldie S. Byrd, PhD, Gary W. Beecham, PhD, Margaret A. Pericak-Vance, PhD, or Dr. Young Juan I. Young, PhD, and Jeffery M. Vance, MD, PhD [email protected] Neurol Genet 2020;6:e404. doi:10.1212/NXG.0000000000000404 Abstract Objective Here, we re-examine TOMM40-5239 as a race/ethnicity-specific risk modifier for late-onset Alzheimer disease (LOAD) with adjustment for local genomic ancestry (LGA) in Apolipo- protein E (APOE) «4 haplotypes. Methods The TOMM40-5239 size was determined by fragment analysis and whole genome sequencing in homozygous APOE «3 and APOE «4 haplotypes of African (AF) or European (EUR) ancestry. The risk for LOAD was assessed within groups by allele size. Results The TOMM40-5239 length did not modify risk for LOAD in APOE «4 haplotypes with EUR or AF LGA. Increasing length of TOMM40-5239 was associated with a significantly reduced risk for LOAD in EUR APOE e3 haplotypes. Conclusions Adjustment for LGA confirms that TOMM40-5239 cannot explain the strong differential risk for LOAD between APOE e4 with EUR and AF LGA. Our study does confirm previous reports that increasing allele length of the TOMM40-5239 repeat is associated with decreased risk for LOAD in carriers of homozygous APOE e3 alleles and demonstrates that this effect is occurring in those individuals with the EUR LGA APOE e3 allele haplotype.
    [Show full text]
  • Superior Frontal Gyrus TOMM40-APOE Locus DNA Methylation in Alzheimer’S Disease
    Journal of Alzheimer’s Disease Reports 5 (2021) 275–282 275 DOI 10.3233/ADR-201000 IOS Press Research Report Superior Frontal Gyrus TOMM40-APOE Locus DNA Methylation in Alzheimer’s Disease Natalia Bezucha,1, Steven Bradburna,1, Andrew C. Robinsonb, Neil Pendletonb, Antony Paytonc and Chris Murgatroyda,∗ aDepartment of Life Sciences, Manchester Metropolitan University, Manchester, UK bFaculty of Biology, Medicine and Health, School of Biological Sciences, Division of Neuroscience & Experimental Psychology, University of Manchester, Salford Royal Hospital, Salford, UK cDivision of Informatics, Imaging & Data Sciences, School of Health Sciences, The University of Manchester, Manchester, UK Accepted 7 March 2021 Pre-press 28 March 2021 Abstract. Background: The APOE ε4 allele is the strongest known genetic risk factor for sporadic Alzheimer’s disease (AD). The neighboring TOMM40 gene has also been implicated in AD due to its close proximity to APOE. Objective: Here we tested whether methylation of the TOMM40-APOE locus may influence ApoE protein levels and AD pathology. Methods: DNA methylation levels across the TOMM40-APOE locus and ApoE levels were measured in superior frontal gyrus tissues of 62 human brains genotyped for APOE and scored for AD neuropathology. Results: Methylation levels within the TOMM40 CpG island in the promoter or APOE CpG island in Exon 4 did not differ between APOE ε4 carriers versus non-carriers. However, APOE ε4 carriers had significantly higher methylation the APOE promoter compared with non-carriers. Although DNA methylation at TOMM40, APOE promoter region, or APOE did not differ between AD pathological groups, there was a negative association between TOMM40 methylation and CERAD scores.
    [Show full text]
  • Genomic Instability in Alzheimer's Disease
    Genomic Instability in Alzheimer’s Disease: TOMM40 Poly-T Variations Kathy Z. Dai1, Omolara-Chinue Glenn1,2, Julio A. Barrera1,2, Ornit Chiba-Falek1,2 1Department of Neurology, Duke University Medical Center, Durham, NC 2Center for Genomic and Computational Biology, Duke University Medical Center, Durham, NC Introduction Methods Results Late-Onset Alzheimer’s Disease (LOAD) accounts for roughly Gene EXpression Gene EXpression 99% of Alzheimer’s cases and is the most common cause of To examine the regulatory role of TOMM40’523 on gene • Using the splice analysis assay (Fig. 3), we were able to dementia. Age is the greatest known risk factor for LOAD. The expression, we first attempted to detect the presence of a rare detect a novel TOMM40 alternative splice variant. next strongest risk factor is genetic background, which accounts alternative splice variant within human brain tissue (Fig. 2). for 58-79% of the predisposition to LOAD1. We developed an assay to analyze TOMM40 splicing: Involvement of chromosome 19q13.32 in LOAD: • mRNA extracted from fresh frozen human brain tissue Brain mRNA • Since 1993, the ε4 allele of APOE has been established as the strongest genetic risk factor for LOAD. • mRNA converted to cDNA using SuperScript III Reverse • GWAS has detected the strongest LOAD association signal cDNA Transcriptase from the 19q13.32 linkage disequilibrium region • cDNA samples amplified using • In 2010, the structural variant TOMM40’523 was associated optimized PCR settings PCR with the age-of-onset of LOAD2. • PCR products sent to Eton AD-179-FC AD-179-TC AD-75-FC AD-75-TC Bioscience for fragment analysis Fragment Normal-795-FC Normal-795-TC • We created a calibration In this project, we aimed to further characterize the TOMM40 using capillary electrophoresis Analysis 20000 curve such that the gene and investigate the functional role of TOMM40’523.
    [Show full text]
  • Mitochondrial Protein Translocases for Survival and Wellbeing
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 588 (2014) 2484–2495 journal homepage: www.FEBSLetters.org Review Mitochondrial protein translocases for survival and wellbeing Anna Magdalena Sokol a, Malgorzata Eliza Sztolsztener a, Michal Wasilewski a, Eva Heinz b,c, ⇑ Agnieszka Chacinska a, a Laboratory of Mitochondrial Biogenesis, International Institute of Molecular and Cell Biology, Warsaw 02-109, Poland b Department of Microbiology, Monash University, Melbourne, Victoria 3800, Australia c Victorian Bioinformatics Consortium, Monash University, Melbourne, Victoria 3800, Australia article info abstract Article history: Mitochondria are involved in many essential cellular activities. These broad functions explicate the Received 28 April 2014 need for the well-orchestrated biogenesis of mitochondrial proteins to avoid death and pathological Revised 15 May 2014 consequences, both in unicellular and more complex organisms. Yeast as a model organism has Accepted 15 May 2014 been pivotal in identifying components and mechanisms that drive the transport and sorting of Available online 24 May 2014 nuclear-encoded mitochondrial proteins. The machinery components that are involved in the Edited by Wilhelm Just import of mitochondrial proteins are generally evolutionarily conserved within the eukaryotic king- dom. However, topological and functional differences have been observed. We review the similari- ties and differences in mitochondrial translocases from yeast to human. Additionally, we provide a Keywords: Cancer systematic overview of the contribution of mitochondrial import machineries to human patholo- HIF1a gies, including cancer, mitochondrial diseases, and neurodegeneration. Mitochondrial disease Ó 2014 Federation of European Biochemical Societies. Published by Elsevier B.V.
    [Show full text]
  • Polymorphism in the TOMM40 Gene Modifies the Risk of Developing
    Available online at www.sciencedirect.com ScienceDirect Neuromuscular Disorders 23 (2013) 969–974 www.elsevier.com/locate/nmd Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms F.L. Mastaglia a,b,⇑, A. Rojana-udomsart a, I. James b, M. Needham a,b, T.J. Day c, L. Kiers c, J.A. Corbett d, A.M. Saunders e, M.W. Lutz e, A.D. Roses e,f, for the Alzheimer’s Disease Neuroimaging Initiative 1 a Australian Neuro-Muscular Research Institute, Centre for Neuromuscular and Neurological Disorders, The University of Western Australia, Queen Elizabeth II Medical Centre, Perth, Western Australia, Australia b Institute for Immunology & Infectious Diseases, Murdoch University, Western Australia, Australia c Departments of Neurology and Neurophysiology, Royal Melbourne Hospital & Department of Medicine, University of Melbourne, Parkville, Victoria, Australia d Department of Neurology, Concord Hospital, Concord, NSW, Australia e Duke University, Durham, NC 27705, USA f Zinfandel Pharmaceuticals, Durham, NC 27705, USA Received 25 June 2013; received in revised form 28 August 2013; accepted 10 September 2013 Abstract A polyT repeat in an intronic polymorphism (rs10524523) in the TOMM40 gene, which encodes an outer mitochondrial membrane translocase involved in the transport of amyloid-b and other proteins into mitochondria, has been implicated in Alzheimer’s disease and APOE-TOMM40 genotypes have been shown to modify disease risk and age at onset of symptoms. Because of the similarities between Alzheimer’s disease and sporadic inclusion body myositis (s-IBM), and the importance of amyloid-b and mitochondrial changes in s-IBM, we investigated whether variation in poly-T repeat lengths in rs10524523 also influence susceptibility and age at onset in a cohort of 90 Caucasian s-IBM patients (55 males; age 69.1 ± 9.6).
    [Show full text]